StockWatch
·
Healthcare Service Provider
Corporate Action19 Sept 2026, 04:25 pm

Choksi Labs to issue 3.5 lakh warrants at ₹177/warrant for ₹6.19 Cr

AI Summary

Choksi Laboratories Ltd's Board of Directors approved the issuance and allotment of up to 3,50,000 fully convertible warrants on a preferential basis to the Promoter and Promoter Group. Each warrant is priced at ₹177, aggregating to a maximum of ₹6,19,50,000. This preferential issue is subject to shareholder approval at an Extra Ordinary General Meeting (EGM) scheduled for Saturday, October 17, 2026, via Video Conferencing or Other Audio-Visual Means. The board also approved the notice for the EGM and appointed CS Surabhi Agrawal as Scrutinizer for the e-voting process. An amount equivalent to 25% of the warrant issue price will be payable at subscription.

Key Highlights

  • Board approved issuing 3.5 lakh convertible warrants.
  • Warrants priced at ₹177 each, totaling ₹6.19 crore.
  • Allotment is on a preferential basis to the Promoter Group.
  • Shareholder approval required at an EGM on October 17, 2026.
  • Each warrant is convertible into one fully paid-up equity share.